Management ChangeJun 24, 2026, 04:02 PM
Kymera Appoints Felix J. Baker as Chairman of Board
AI Summary
Kymera Therapeutics announced the appointment of Felix J. Baker, PhD, as the new Chairman of its Board of Directors. Dr. Baker, who has been the Lead Independent Director since 2024, succeeds co-founder Bruce Booth, DPhil. Dr. Booth will continue to serve as an Independent Director, ensuring continuity and leveraging his decade of leadership. The company highlighted Dr. Baker's extensive experience in scaling innovative companies and translating science into medicines as invaluable for Kymera's next phase of growth.
Key Highlights
- Felix J. Baker, PhD, appointed Chairman of Kymera Therapeutics' Board of Directors.
- Dr. Baker succeeds Bruce Booth, DPhil, who served as Chairman since 2016.
- Bruce Booth will remain an Independent Director on the Board.
- Dr. Baker has served as Kymera's Lead Independent Director since 2024.
- Dr. Baker is a Managing Member of Baker Brothers Investments, which he co-founded in 2000.
- Dr. Baker holds a BS and PhD in Immunology from Stanford University.
Price Impact
More from KYMR